Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
University of California, San Francisco
Decibel Therapeutics
Presage Biosciences
Washington University School of Medicine
Livzon Pharmaceutical Group Inc.
Advance Biofactures Corporation
Duke University
University of California, San Francisco
University of Florida
Brigham and Women's Hospital
University of Oklahoma